| HP1/HP1′ |
F(163..570)/C(26563..27591) |
Secretory pathway; transmembrane region |
| F-LANA/F-LANA′ |
F(3391..4416)/C(26563..27591) |
Nuclear localization; N-terminal DNA-binding domain |
| F-ICP0/F-ICP0′ |
F(6387..7202)/C(23780..24595) |
Similar to TAF9 RNA polymerase II; Nucleotidylylation signature |
| HP4/HP4′ |
F(6484..7146)/C(23836..24498) |
Hypothetical protein; ORF overlapping with F-ICP0 |
| HP6/HP13 |
F(8063..8833)/C(22137..22919) |
Nuclear localization; ORFs extending into US; N-terminally identical proteins |
| HP7/HP11 |
F(8349..8900)/C(22118..22633) |
Nuclear localization; ORFs overlapping with HP6/13 and extending into US; N-terminally identical proteins |
| LF3-like/LF3-like′ |
C(12..1916)/F(29066..30970) |
Leucine Zipper motif; C-termianl RNA-binding domain; similar to LF3 of Cercopithecine herpesvirus 15; nuclear localization; |
| F-ICP4a/F-ICP4a′ |
C(86..2041)/F(28941..30896) |
Nuclear localization; remote similarity to ICP4; Nucleotidylylation signature |
| HP2/HP2′ |
C(3693..4373)/F(26609..27289) |
Similarity to germ line helicase; overlapping F-LANA on the opposite strand |
| HP3/HP3′ |
C(4782..5105)/F(25877..26200) |
Putative membrane protein; transmembrane helix: aa 33–55 |
| HP5/HP5′ |
C(7007..7543)/F(23439..23975 |
Secretory pathway; transmembrane region: aa 10–27 |
| HP8/HP12 |
C(8289..8831)/F(22127..22693) |
Nuclear localization; products identical within C-terminus |
